TrialCell reports. Medicine2026

Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy.

Cornelia D Cudrici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.